Stay updated on BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial

Sign up to get notified when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s interface release rather than the underlying study details.
    Difference
    0.0%
    Check dated 2026-04-25T18:52:09.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T13:50:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Follicular lymphoma was added to the conditions section and the Genetic and Rare Diseases Information Center resources reference was included.
    Difference
    0.1%
    Check dated 2026-03-28T03:04:05.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing the previous v3.4.3 entry.
    Difference
    0.0%
    Check dated 2026-03-21T00:48:01.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:00:12.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page shows a new UI revision label 'Revision: v3.4.2' replacing the previous 'Revision: v3.4.1'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:22:22.000Z thumbnail image

Stay in the know with updates to BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.